|
Market Closed -
Toronto S.E.
15:53:15 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 0.4600 CAD | -1.08% |
|
-3.16% | +1.10% |
| 08-27 | Pharmacorp Rx Inc. Announces Board and Committee Changes, Effective from August 31, 2026 | CI |
| 08-20 | PharmaCorp Rx Swings to Q2 Profit as Revenue Jumps | MT |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 46.5x | - | 1.73x | 21.56x | 50.58x | 58.76M | |
| -.--% | -.--% | 16.7x | 1.51x | 0.67x | 10.02x | 10.9x | 14.89B | |
| 2.21% | 2.53% | 16.85x | 1.74x | 0.76x | 7.91x | 9.92x | 6.64B | |
| 1.07% | 1.33% | 20.89x | 2.31x | 0.8x | 13.4x | 13.65x | 6.47B | |
| 2.89% | 3.31% | 14.53x | 2.15x | 0.89x | 6.15x | 8.36x | 4.09B | |
| 5.57% | 6.11% | 14.45x | 4.38x | 1.24x | 7.59x | 14.23x | 3.22B | |
| 5.16% | 5.72% | 13.99x | 2.65x | 0.59x | 4.55x | 7.5x | 3.09B | |
| 4.79% | 5.26% | 13.57x | 6.09x | 0.81x | 6.07x | 8.45x | 2.86B | |
| 2.17% | 2.59% | 18.65x | 3.26x | 0.56x | 7.11x | 11.64x | 1.4B | |
| 0.02% | -.--% | -115.68x | 2.4x | 0.4x | 14.5x | 52.26x | 1.34B | |
| 3.18% | 4.34% | 14.46x | 0.88x | 0.3x | 2.82x | 7.21x | 971M | |
| 6.09% | 5.33% | 20.28x | 2.38x | 0.82x | 7.58x | 18.05x | 869M | |
| 1.3% | 1.88% | 27.53x | 7.51x | 1x | 13.58x | 21.06x | 836M | |
| Average | 2.87% | 3.2% | 9.44x | 3.11x | 0.81x | 9.45x | 17.99x | 3.6B | |
| Weighted average by Cap. | 2% | 2.26% | 13.10x | 2.45x | 0.75x | 9.00x | 12.27x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
